Instead, lower doses of anti-VEGF therapy have been more successful in normalizing the tumor vasculature, increasing perfusion and enhancing T cell infiltration, suggesting that the judicious use of antiangiogenic agents is a promising strategy for cancer treatment 132. Here, VEGFA is linked to neoplasm.